Goldline Pharmaceuti Stock Price Analysis and Quick Research Report. Is Goldline Pharmaceuti an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Goldline Pharmaceuti. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Goldline Pharmaceuti has a PE ratio of 19.2290756359449 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Goldline Pharmaceuti has ROA of 11.5177% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Goldline Pharmaceuti has a Current ratio of 1.9847.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Goldline Pharmaceuti has a ROE of 38.8119%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Goldline Pharmaceuti has a Debt to Equity ratio of 1.0658 which means that the company has low proportion of debt in its capital.

• Sales growth: Goldline Pharmaceuti has reported revenue growth of 19.0516% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Goldline Pharmaceuti for the current financial year is 21.5852750065049%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Goldline Pharmaceuti is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Goldline Pharmaceuti is Rs 2.9523. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Goldline Pharmaceuti in Ticker for free. Also, one can get the intrinsic value of Goldline Pharmaceuti by using Valuation Calculators, which are available with a Finology ONE subscription. 

Goldline Pharmaceuti FAQs

Q1. What is Goldline Pharmaceuti share price today?
Ans: The current share price of Goldline Pharmaceuti is Rs 56.77.

Q2. What is the market capitalisation of Goldline Pharmaceuti?
Ans: Goldline Pharmaceuti has a market capitalisation of Rs 54.4992 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Goldline Pharmaceuti?
Ans: The PE ratio of Goldline Pharmaceuti is 19.2290756359449 and the P/B ratio of Goldline Pharmaceuti is 2.70382259646984, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Goldline Pharmaceuti share?
Ans: The 52-week high share price of Goldline Pharmaceuti is Rs 60, and the 52-week low share price of Goldline Pharmaceuti is Rs 56.77.

Q5. Does Goldline Pharmaceuti pay dividends?
Ans: Currently, Goldline Pharmaceuti does not pay dividends. Dividend yield of Goldline Pharmaceuti is around 0%.

Q6. What are the face value and book value of Goldline Pharmaceuti shares?
Ans: The face value of Goldline Pharmaceuti shares is Rs 10, while the book value per share of Goldline Pharmaceuti is around Rs 20.9962. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Goldline Pharmaceuti?
Ans: Goldline Pharmaceuti has a total debt of Rs 11.0344 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Goldline Pharmaceuti?
Ans: The ROE of Goldline Pharmaceuti is 38.8119% and ROCE of Goldline Pharmaceuti is 28.7525%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Goldline Pharmaceuti a good buy for the long term?
Ans: The Goldline Pharmaceuti long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Goldline Pharmaceuti undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Goldline Pharmaceuti appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Goldline Pharmaceuti’s financials?
Ans: You can review Goldline Pharmaceuti’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.